198 related articles for article (PubMed ID: 22569733)
1. OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability.
Bao H; Jin X; Li L; Lv F; Liu T
J Mater Sci Mater Med; 2012 Aug; 23(8):1891-901. PubMed ID: 22569733
[TBL] [Abstract][Full Text] [Related]
2. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26.
Pang Z; Lu W; Gao H; Hu K; Chen J; Zhang C; Gao X; Jiang X; Zhu C
J Control Release; 2008 Jun; 128(2):120-7. PubMed ID: 18436327
[TBL] [Abstract][Full Text] [Related]
3. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.
Durán-Lobato M; Muñoz-Rubio I; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
J Biomed Nanotechnol; 2014 Jun; 10(6):1068-79. PubMed ID: 24749401
[TBL] [Abstract][Full Text] [Related]
5. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles.
Verma RK; Pandya S; Misra A
J Biomed Nanotechnol; 2011 Feb; 7(1):118-20. PubMed ID: 21485832
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of osteoinduction by continual simvastatin release from poly(lactic-co-glycolic acid)-hydroxyapatite-simvastatin nano-fibrous scaffold.
Jiang L; Sun H; Yuan A; Zhang K; Li D; Li C; Shi C; Li X; Gao K; Zheng C; Yang B; Sun H
J Biomed Nanotechnol; 2013 Nov; 9(11):1921-8. PubMed ID: 24059091
[TBL] [Abstract][Full Text] [Related]
7. Silymarin encapsulated poly(D,L-lactic-co-glycolic acid) nanoparticles: a prospective candidate for prostate cancer therapy.
Snima KS; Arunkumar P; Jayakumar R; Lakshmanan VK
J Biomed Nanotechnol; 2014 Apr; 10(4):559-70. PubMed ID: 24734508
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic polylactic acid-hyperbranched polyglycerol nanoparticles as a controlled release system for poorly water-soluble drugs: physicochemical characterization.
Gao X; Zhang X; Zhang X; Wang Y; Sun L; Li C
J Pharm Pharmacol; 2011 Jun; 63(6):757-64. PubMed ID: 21585372
[TBL] [Abstract][Full Text] [Related]
9. Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2h-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution.
Gomes AJ; Faustino AS; Machado AE; Zaniquelli ME; de Paula Rigoletto T; Lunardi CN; Lunardi LO
Drug Deliv; 2006; 13(6):447-54. PubMed ID: 17002973
[TBL] [Abstract][Full Text] [Related]
10. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of a poly(lactic-co-glycolic acid) core + poly(N-isopropylacrylamide) shell nanoparticle system.
Kosinski AM; Brugnano JL; Seal BL; Knight FC; Panitch A
Biomatter; 2012; 2(4):195-201. PubMed ID: 23507885
[TBL] [Abstract][Full Text] [Related]
12. Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application.
Moura CC; Segundo MA; Neves Jd; Reis S; Sarmento B
Int J Nanomedicine; 2014; 9():4911-22. PubMed ID: 25364249
[TBL] [Abstract][Full Text] [Related]
13. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
[TBL] [Abstract][Full Text] [Related]
14. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.
Loureiro JA; Gomes B; Fricker G; Coelho MAN; Rocha S; Pereira MC
Colloids Surf B Biointerfaces; 2016 Sep; 145():8-13. PubMed ID: 27131092
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation.
Toman P; Lien CF; Ahmad Z; Dietrich S; Smith JR; An Q; Molnár É; Pilkington GJ; Górecki DC; Tsibouklis J; Barbu E
Acta Biomater; 2015 Sep; 23():250-262. PubMed ID: 25983313
[TBL] [Abstract][Full Text] [Related]
16. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC
Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral activity of L-ascorbic acid-poly- D,L-(lactide-co-glycolide) nanoparticles containing violacein.
Martins D; Frungillo L; Anazzetti MC; Melo PS; Durán N
Int J Nanomedicine; 2010 Feb; 5():77-85. PubMed ID: 20161989
[TBL] [Abstract][Full Text] [Related]
19. Antihyperalgesic effect of simultaneously released hydromorphone and bupivacaine from polymer fibers in the rat chronic constriction injury model.
Hasirci V; Bonney I; Goudas LC; Shuster L; Carr DB; Wise DL
Life Sci; 2003 Nov; 73(26):3323-37. PubMed ID: 14572875
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method.
Cui F; Cun D; Tao A; Yang M; Shi K; Zhao M; Guan Y
J Control Release; 2005 Oct; 107(2):310-9. PubMed ID: 16255081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
